Amantadine and Rimantadine Analogues—Single-Crystal Analysis and Anti-Coronaviral Activity
暂无分享,去创建一个
K. Shishkova | S. Shishkov | B. Shivachev | R. Rusew | H. Sbirkova-Dimitrova | I. Stankova | R. Chayrov | Antoniya Stoymirska | Boris Shivachev
[1] A. Mardinoğlu,et al. In Vitro and In Vivo Neuroprotective Effects of Sarcosine , 2022, BioMed research international.
[2] R. Liu,et al. Synthesis, Neuroprotective Effect and Physicochemical Studies of Novel Peptide and Nootropic Analogues of Alzheimer Disease Drug , 2022, Pharmaceuticals.
[3] B. Shivachev,et al. Development of N,N-Dimethylglycine-Amantadine for Adjunctive Dopaminergic Application: Synthesis, Structure and Biological Activity , 2022, Crystals.
[4] Xingxing Ma,et al. Unsymmetric monothiooxalamides from S8, bromodifluoro reagents and anilines: Synthesis and applications , 2022, Tetrahedron Chem.
[5] Yang Yang,et al. Recovery of N, N-dimethylglycine (DMG) from dimethylglycine hydrochloride by bipolar membrane electrodialysis , 2022, Chemical Engineering and Processing - Process Intensification.
[6] J. Bukh,et al. Efficacy of Ion-Channel Inhibitors Amantadine, Memantine and Rimantadine for the Treatment of SARS-CoV-2 In Vitro , 2021, Viruses.
[7] E. Marengo,et al. Understanding protection from SARS-CoV-2 using metabolomics , 2021, Scientific Reports.
[8] R. Butterworth. Potential for the Repurposing of Adamantane Antivirals for COVID-19 , 2021, Drugs in R&D.
[9] Jorge L. Arias-Arias,et al. In Vitro Inhibition of Zika Virus Replication with Amantadine and Rimantadine Hydrochlorides , 2021, Microbiology Research.
[10] S. Olsen,et al. Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti–COVID-19 drug design , 2020, Science Advances.
[11] G. Minasov,et al. High-resolution structures of the SARS-CoV-2 2’-O-methyltransferase reveal strategies for structure-based inhibitor design , 2020, Science Signaling.
[12] G. Melagraki,et al. Synthetic Analogues of Aminoadamantane as Influenza Viral Inhibitors—In Vitro, In Silico and QSAR Studies , 2020, Molecules.
[13] Jianping Hu,et al. COVID-19 Docking Server: A meta server for docking small molecules, peptides and antibodies against potential targets of COVID-19 , 2020, Bioinform..
[14] A. Joachimiak,et al. Crystal structures of SARS-CoV-2 ADP-ribose phosphatase: from the apo form to ligand complexes , 2020, IUCrJ.
[15] L. Dodd,et al. Remdesivir for the Treatment of Covid-19 — Final Report , 2020, The New England journal of medicine.
[16] Yan Zhang,et al. Structural Basis for the Inhibition of the RNA-Dependent RNA Polymerase from SARS-CoV-2 by Remdesivir , 2020, bioRxiv.
[17] Hualiang Jiang,et al. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors , 2020, Nature.
[18] A. Majouga,et al. Synthesis and cytotoxicity of oxindoles dispiro derivatives with thiohydantoin and adamantane fragments , 2020 .
[19] Z. Rao,et al. Delicate structural coordination of the Severe Acute Respiratory Syndrome coronavirus Nsp13 upon ATP hydrolysis , 2019, Nucleic acids research.
[20] M. Christmann,et al. Corrigendum: Mechanistic Studies on the Organocatalytic α-Chlorination of Aldehydes: The Role and Nature of Off-Cycle Intermediates. , 2018, Angewandte Chemie.
[21] I. Godovikov,et al. Stereoselective synthesis of novel adamantane derivatives with high potency against rimantadine-resistant influenza A virus strains. , 2017, Organic & biomolecular chemistry.
[22] Liming Yan,et al. Structural basis and functional analysis of the SARS coronavirus nsp14–nsp10 complex , 2015, Proceedings of the National Academy of Sciences.
[23] G. Sheldrick. SHELXT – Integrated space-group and crystal-structure determination , 2015, Acta crystallographica. Section A, Foundations and advances.
[24] Louis J. Farrugia,et al. WinGX and ORTEP for Windows: an update , 2012 .
[25] Roman A. Laskowski,et al. LigPlot+: Multiple Ligand-Protein Interaction Diagrams for Drug Discovery , 2011, J. Chem. Inf. Model..
[26] Silvia Domcke,et al. Molecular mechanisms for the RNA-dependent ATPase activity of Upf1 and its regulation by Upf2. , 2011, Molecular cell.
[27] David S. Goodsell,et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..
[28] Arthur J. Olson,et al. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..
[29] S. Hamodrakas,et al. A de novo Designed Possible 5‐Lipoxygenase Inhibitor: α‐Acetoxy‐N‐[1‐(1‐tricyclo[3.3.1.13,7]dec‐1‐yl)ethyl]benzeneacetamide , 1996 .
[30] K. Sudo,et al. A sensitive assay system screening antiviral compounds against herpes simplex virus type 1 and type 2. , 1994, Journal of virological methods.
[31] S. Gellman,et al. Effects of covalent modifications on the solid-state folding and packing of N-malonylglycine derivatives , 1992 .
[32] G. M. Reisner,et al. Space‐group changes – revised structures of seven compounds , 1990 .
[33] T. Mosmann. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.
[34] S. Brenner. Repurposing of Adamantanes with Transmitter Receptor Antagonist Properties for the Prevention/Treatment of COVID-19 , 2020 .
[35] A. Trzeciak,et al. New coupling reagents in peptide chemistry , 1989 .
[36] Paul D Adams,et al. Electronic Reprint Biological Crystallography Electronic Ligand Builder and Optimization Workbench (elbow ): a Tool for Ligand Coordinate and Restraint Generation Biological Crystallography Electronic Ligand Builder and Optimization Workbench (elbow): a Tool for Ligand Coordinate and Restraint Gener , 2022 .